115 related articles for article (PubMed ID: 17479103)
1. Inhibition of telomerase RNA (hTR) in cervical cancer by adenovirus-delivered siRNA.
Li Y; Li H; Yao G; Li W; Wang F; Jiang Z; Li M
Cancer Gene Ther; 2007 Aug; 14(8):748-55. PubMed ID: 17479103
[TBL] [Abstract][Full Text] [Related]
2. [Therapeutic effects of hTR-siRNA adenovirus on human cervical cancer xenografts in nude mice].
Li WY; Li MY; Xiao LY; Zhang CL; Liu YR; Li XY; Zhang SY; Li Y
Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Sep; 39(5):711-4, 731. PubMed ID: 19024296
[TBL] [Abstract][Full Text] [Related]
3. [Construction of adenovirus expressing siRNA against hTR and its anti-tumor activity in vitro].
Li Y; Xiao LY; Yao G; Li H; Yang ZW; Li WY; Jiang ZH; Li MY
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Jun; 24(6):570-3. PubMed ID: 18538086
[TBL] [Abstract][Full Text] [Related]
4. Telomerase inhibition strategies by siRNAs against either hTR or hTERT in oral squamous cell carcinoma.
Li Y; Li M; Yao G; Geng N; Xie Y; Feng Y; Zhang P; Kong X; Xue J; Cheng S; Zhou J; Xiao L
Cancer Gene Ther; 2011 May; 18(5):318-25. PubMed ID: 21233858
[TBL] [Abstract][Full Text] [Related]
5. Long-term suppression of telomerase expression in HeLa cell clones, transfected with an expression vector carrying siRNA targeting hTERT mRNA.
Kurvinen K; Syrjänen S; Johansson B
Int J Oncol; 2006 Jul; 29(1):279-88. PubMed ID: 16773210
[TBL] [Abstract][Full Text] [Related]
6. Combination therapy of malignant glioma cells with 2-5A-antisense telomerase RNA and recombinant adenovirus p53.
Komata T; Kondo Y; Koga S; Ko SC; Chung LW; Kondo S
Gene Ther; 2000 Dec; 7(24):2071-9. PubMed ID: 11223987
[TBL] [Abstract][Full Text] [Related]
7. Delivering antisense telomerase RNA by a hybrid adenovirus/ adeno-associated virus significantly suppresses the malignant phenotype and enhances cell apoptosis of human breast cancer cells.
Zhang X; Chen Z; Chen Y; Tong T
Oncogene; 2003 Apr; 22(16):2405-16. PubMed ID: 12717417
[TBL] [Abstract][Full Text] [Related]
8. Knockdown of hTERT by siRNA inhibits cervical cancer cell growth in vitro and in vivo.
Shi YA; Zhao Q; Zhang LH; Du W; Wang XY; He X; Wu S; Li YL
Int J Oncol; 2014 Sep; 45(3):1216-24. PubMed ID: 24920549
[TBL] [Abstract][Full Text] [Related]
9. Attenuation of telomerase activity by hammerhead ribozymes targeting human telomerase RNA and telomerase reverse transcriptase in pancreatic carcinoma cells.
Hayashidani Y; Hiyama E; Murakami Y; Sueda T
Hiroshima J Med Sci; 2005 Mar; 54(1):21-7. PubMed ID: 15847061
[TBL] [Abstract][Full Text] [Related]
10. [Combination of antisense human telomerase RNA and antisense human telomerase catalytic subunit inhibits cervical cancer Hela cells growth].
Lei LX; Chen ZD
Zhonghua Fu Chan Ke Za Zhi; 2005 Jan; 40(1):42-6. PubMed ID: 15774092
[TBL] [Abstract][Full Text] [Related]
11. Selective ablation of human cancer cells by telomerase-specific adenoviral suicide gene therapy vectors expressing bacterial nitroreductase.
Bilsland AE; Anderson CJ; Fletcher-Monaghan AJ; McGregor F; Evans TR; Ganly I; Knox RJ; Plumb JA; Keith WN
Oncogene; 2003 Jan; 22(3):370-80. PubMed ID: 12545158
[TBL] [Abstract][Full Text] [Related]
12. [Effects of combining siRNA-TR and TERT upon telomerase activity and in vitro growth inhibition in transitional cancer of bladder BIU-87 cell line].
Cheng W; Su Y; Ma HQ; Wei ZF; Gao JP; Zhang ZY; Ge JP; Jing KZ; Xu F
Zhonghua Yi Xue Za Zhi; 2009 Nov; 89(40):2847-52. PubMed ID: 20137667
[TBL] [Abstract][Full Text] [Related]
13. Treatment of prostate cancer in vitro and in vivo with 2-5A-anti-telomerase RNA component.
Kondo Y; Koga S; Komata T; Kondo S
Oncogene; 2000 Apr; 19(18):2205-11. PubMed ID: 10822370
[TBL] [Abstract][Full Text] [Related]
14. Autophagic cell death of malignant glioma cells induced by a conditionally replicating adenovirus.
Ito H; Aoki H; Kühnel F; Kondo Y; Kubicka S; Wirth T; Iwado E; Iwamaru A; Fujiwara K; Hess KR; Lang FF; Sawaya R; Kondo S
J Natl Cancer Inst; 2006 May; 98(9):625-36. PubMed ID: 16670388
[TBL] [Abstract][Full Text] [Related]
15. 2-5A antisense therapy directed against human telomerase RNA inhibits telomerase activity and induces apoptosis without telomere impairment in cervical cancer cells.
Yatabe N; Kyo S; Kondo S; Kanaya T; Wang Z; Maida Y; Takakura M; Nakamura M; Tanaka M; Inoue M
Cancer Gene Ther; 2002 Jul; 9(7):624-30. PubMed ID: 12082463
[TBL] [Abstract][Full Text] [Related]
16. [Experimental study on adenovirus-mediated transfer of p53 or adenovirus- mediated transfer of p53 combined with radiotherapy for human cervical cancer cell line HeLa cells].
Kong W; Sun J; Lin C; Zha Y; Lu G; Fu M; Zhang X
Zhonghua Fu Chan Ke Za Zhi; 2002 Jun; 37(6):352-5. PubMed ID: 12126571
[TBL] [Abstract][Full Text] [Related]
17. [Construction of a retroviral vector for RNA interference targeting human telomerase reverse transcriptase].
Wang QS; Wang XL; Li H; Wang QY; Wang QY; Yang GX
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Dec; 26(12):1715-9. PubMed ID: 17259104
[TBL] [Abstract][Full Text] [Related]
18. [The efficacy of autocatalytic casapse-3 driven by human telomerase reverse transcriptase promoter on human ovarian carcinoma].
Song Y; Shen K; Yu JR
Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(41):2919-24. PubMed ID: 18261307
[TBL] [Abstract][Full Text] [Related]
19. Antitumor activity of an oncolytic adenovirus-delivered oncogene small interfering RNA.
Zhang YA; Nemunaitis J; Samuel SK; Chen P; Shen Y; Tong AW
Cancer Res; 2006 Oct; 66(19):9736-43. PubMed ID: 17018633
[TBL] [Abstract][Full Text] [Related]
20. [Study on apoptosis of human cervical carcinoma HeLa cells with RNA interference targeting hTERT].
Zhao Y; Ren JL; Zhang R; Ma LY; Bao W; Wang CJ; Yang AG
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2005 Jul; 21(4):524-6. PubMed ID: 15989808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
